Get started
Author

Anja Barač Nekić

Observed names: A Barac Nekic, A Barač Nekić, A. Barac Nekic, Anja Barac, Anja Barac Nekic, AnjaBarac Nekic, Barac Nekic A, Nekic Anja Barac, Nekić Anja Barač
ORCID: 0000-0003-2672-8529
Observed ORCID: 0000-0003-2672-8529
OpenAlex ID: A5060594952
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
2022 · Timo Deutschbein, Giuseppe Reimondo, et al. · The Lancet Diabetes & Endocrinology · 198
The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study
2021 · Anja Barac, Paola Krnjaic, et al. · Work · 18
Are comorbidities of patients with adrenal incidentaloma tied to sex?
2024 · Soraya Puglisi, Anja Barač Nekić, et al. · Frontiers in Endocrinology · 9
PDF
Adverse Events of Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
2024 · Ivana Dora Vodanović, Anja Barač Nekić, et al. · Endocrine Research · 4
The Effect of Surgeon Expertise on the Outcome of Patients with Adrenocortical Carcinoma
2022 · Anja Barac Nekic, Nikola Knezevic, et al. · Journal of Personalized Medicine · 4
PDF
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 · Alessandra Mangone, Barbara Altieri, et al. · European Journal of Endocrinology · 3
Germline targeted next-generation sequencing in patients with adrenal incidentalomas
2025 · Erika Messina, Alessia Inglesi, et al. · Frontiers in Endocrinology · 3
PDF
Precipitating factors of diabetic ketoacidosis
2022 · Nino Matas, Nekić Anja Barač, et al. · Endocrine Abstracts · 2
38O Clinical predictors of treatment response in advanced adrenocortical carcinoma: A multicentre ENSAT study
2025 · A. Mangone, B. Altieri, et al. · ESMO Open · 1
PDF
Treatment Outcomes in Patients with Recurrent Adrenocortical Carcinoma
2024 · Tamara Dojcinovic, Karin Zibar Tomsic, et al. · Endocrine Research · 1
Mitotane side effects in the treatment of patients with adrenocortical carcinoma - a retrospective study
2022 · Nekic Anja Barac, Tomšić Karin Zibar, et al. · Endocrine Abstracts · 1
Severity and management of hypercortisolism in patients with adrenocortical carcinoma and overt Cushing syndrome
2026 · Marta Araujo-Castro, Irina Bancos, et al. · The Journal of Clinical Endocrinology & Metabolism
AD14 Recovery of adrenal function after adjuvant mitotane discontinuation in patients with adrenocortical carcinoma: results from two referral centres
2026 · M Đukić, A Barač Nekić, et al. · European Journal of Endocrinology
PDF
CB05 Palopegteriparatide in chronic hypoparathyroidism and malabsorption: a case report
2026 · L Kurtović, A Barač Nekić, et al. · European Journal of Endocrinology
PDF
AD12 Metastatic parotid carcinoma as a rare cause of ectopic Cushing syndrome: two case reports
2026 · M Mejašić, A Barač Nekić, et al. · European Journal of Endocrinology
PDF
ER05 Acute kidney injury due to severe hypercalcemia as the initial presentation of parathyroid carcinoma: a case report
2026 · M Pudic, A Barac Nekic, et al. · European Journal of Endocrinology
PDF
EP910 - ECE_2626 - Predictors of malignancy in pheochromocytoma and paraganglioma
2026 · Mirjana Đukić, Ivana Kraljevic, et al. · European Journal of Endocrinology
PDF
P222 - ECE_2363 - Therapeutic outcomes, genetic background, and survival in metastatic pheochromocytoma and paraganglioma: a single-center cohort study
2026 · Nikolina Vučenović, Mirsala Solak, et al. · European Journal of Endocrinology
PDF
EP320 - ECE_2901 - Palopegteriparatide treatment for chronic hypoparathyroidism: a report of three cases
2026 · Karmelo Lovric, Anja Barac Nekic, et al. · European Journal of Endocrinology
PDF
Impact of postoperative hydrocortisone replacement dose on health-related quality of life and metabolic parameters in patients with cured Cushing’s syndrome: randomized, open-label, controlled trial
2026 · Anja Barac Nekic, Darko Kastelan, et al. · Endocrine
Clinical predictors of treatment response in advanced adrenocortical carcinoma: a multicentre ENSAT study
2025 · Alessandra Mangone, Barbara Altieri, et al. · Endocrine Abstracts
Factors influencing the time to achieve target mitotane concentration
2025 · Nikolina Vučenović Bašić, Anja Barač Nekić, et al. · Endocrine Abstracts
Evolution of small (=4 cm) adrenal lesions diagnosed as adrenocortical carcinomas: a5 multicenter retrospective cohort study
2025 · Villavicencio Torres Camila A., Kai Yu, et al. · Endocrine Abstracts
Prognostic factors for survival in patients with metastatic adrenocortical carcinoma
2025 · Nekic Anja Barac, Tomšić Karin Zibar, et al. · Endocrine Abstracts
How ready are endocrine scientists to share retrospective clinical data for research: a perspective from the European Network for the Study of Adrenal Tumors
2025 · Antoan Stefan Sojat, Bastien Rance, et al. · European Journal of Endocrinology
PDF
Works count: 37
Citation count: 243
H-index: 4
I10-index: 2
Year
Topic
Type